Technology
Narrow Band Imaging™ (NBI™) is the world’s only patented endoscopic light technology that enables effective targeting of biopsies not seen under white light without the need for dyes or drugs.
NBI™ Technology enables improved visualization of lesion boundaries in Non-Muscle-Invasive Bladder Cancer (NMIBC) patients.
Studies* have shown that NBI™ Technology visualized
- 17% additional patients with NMIBC
- 24% additional tumors
- 28% additional Carcinoma in Situ (CIS)
* Based on a weighted average.
NBI™ Technology works by filtering white light into specific light wavelengths that are absorbed by hemoglobin providing enhanced visualization of capillary networks and mucosal morphology. NBI™ Technology is not intended to to replace histopathological sampling as a means of diagnosis.
NBI™ Technology Clinical Studies:
- Diagnosis of narrow-band imaging in non-muscle-invasive bladder cancer: A systematic review and meta-analysis study summary
- A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences study summary
- Evaluation of narrow-band imaging as a complementary method for the detection of bladder cancer study summary
- Narrow Band Imaging cystoscopy and bipolar plasma vaporization for large non-muscle-invasive bladder tumors--results of a prospective, randomized comparison to the standard approach
- Narrow Band Imaging™ Technology cystoscopy improves the detection of non-muscle-invasive bladder cancer
- Narrow Band Imaging™ Technology for detecting residual/recurrent cancerous tissue during second transurethral resection of newly-diagnosed non-muscle-invasive high-grade bladder cancer
- Evaluation of Narrow Band Imaging™ Technology as a complementary method for the detection of bladder cancer
- Narrow Band Imaging™ Technology flexible cystoscopy in the detection of primary non-muscle-invasive bladder cancer: a ''second look'' matters?
View Products Featuring NBI™ Technology
Contact an Olympus Representative
